Vitamin K Market Projections | Industry Size Report, 2023-2032

Vitamin K Market - By Type (Vitamin K1, Vitamin K2), By Application (Osteoporosis, Vitamin K-Dependent Clotting Factors Deficiency, Vitamin K Deficiency Bleeding), Route of Administration, Distribution Channel & forecast, 2023-2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Industry coverage

1.2&nbsp;&nbsp;&nbsp; Market scope and definitions

1.3&nbsp;&nbsp;&nbsp; Base estimates and working

1.3.1&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; Covid-19 impact analysis at global level

1.6&nbsp;&nbsp;&nbsp; Data validation

1.7&nbsp;&nbsp;&nbsp; Data sources

1.7.1&nbsp;&nbsp;&nbsp; Primary

1.7.2&nbsp;&nbsp;&nbsp; Secondary

1.7.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.7.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Vitamin K industry 3600 synopsis, 2018 - 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Type trends

2.1.3&nbsp;&nbsp;&nbsp; Application trends

2.1.4&nbsp;&nbsp;&nbsp; Route of administration trends

2.1.5&nbsp;&nbsp;&nbsp; Distribution channel trends

2.1.6&nbsp;&nbsp;&nbsp; Regional trends

Chapter 3&nbsp;&nbsp;&nbsp;Vitamin K Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry segmentation

3.2&nbsp;&nbsp;&nbsp; Industry landscape, 2018 &ndash; 2032

3.3&nbsp;&nbsp;&nbsp; Industry impact forces

3.3.1&nbsp;&nbsp;&nbsp; Growth drivers

3.3.1.1&nbsp;&nbsp;&nbsp;Rising number of coagulation disorders and chronic diseases globally

3.3.1.2&nbsp;&nbsp;&nbsp;Lifestyle and dietary changes leading to deficiency of vitamin K in developing countries

3.3.1.3&nbsp;&nbsp;&nbsp;Increasing awareness and demand of vitamin supplements

3.3.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.3.2.1&nbsp;&nbsp;&nbsp;Side effects associated with vitamin K dosage

3.4&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4.1&nbsp;&nbsp;&nbsp; By type

3.4.2&nbsp;&nbsp;&nbsp; By application

3.4.3&nbsp;&nbsp;&nbsp; By route of administration

3.4.4&nbsp;&nbsp;&nbsp; By distribution channel

3.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.6&nbsp;&nbsp;&nbsp; Regulatory landscape

3.7&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Company positioning matrix, 2022

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players, 2022

4.5&nbsp;&nbsp;&nbsp; Strategic outlook matrix, 2022

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard, 2022

Chapter 5&nbsp;&nbsp;&nbsp;Vitamin K Market, By Type

5.1&nbsp;&nbsp;&nbsp; Key type trends

5.2&nbsp;&nbsp;&nbsp; Vitamin K1

5.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.3&nbsp;&nbsp;&nbsp; Vitamin K2

5.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;Vitamin K Market, By Application

6.1&nbsp;&nbsp;&nbsp; Key application trends

6.2&nbsp;&nbsp;&nbsp; Osteoporosis

6.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.3&nbsp;&nbsp;&nbsp; Vitamin K-dependent clotting factors deficiency (VKCFD)

6.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.4&nbsp;&nbsp;&nbsp; Prothrombin deficiency

6.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.5&nbsp;&nbsp;&nbsp; Vitamin K deficiency bleeding (VKDB)

6.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.6&nbsp;&nbsp;&nbsp; Dermal applications

6.6.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.7&nbsp;&nbsp;&nbsp; Other applications

6.7.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7&nbsp;&nbsp;&nbsp;Vitamin K Market, By Route of Administration

7.1&nbsp;&nbsp;&nbsp; Key route of administration trends

7.2&nbsp;&nbsp;&nbsp; Oral

7.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.2&nbsp;&nbsp;&nbsp; Pills

7.2.2.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.3&nbsp;&nbsp;&nbsp; Powders

7.2.3.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

7.2.4&nbsp;&nbsp;&nbsp; Liquids

7.2.4.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

7.3&nbsp;&nbsp;&nbsp; Parenteral

7.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.4&nbsp;&nbsp;&nbsp; Topical

7.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8&nbsp;&nbsp;&nbsp;Vitamin K Market, By Distribution Channel

8.1&nbsp;&nbsp;&nbsp; Key distribution channel trends

8.2&nbsp;&nbsp;&nbsp; Offline

8.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

8.2.2&nbsp;&nbsp;&nbsp; Hypermarkets/ Supermarkets

8.2.2.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

8.2.3&nbsp;&nbsp;&nbsp; Specialty stores

8.2.3.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million

8.2.4&nbsp;&nbsp;&nbsp; Pharmacy stores

8.2.4.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million

8.3&nbsp;&nbsp;&nbsp; Online

8.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9&nbsp;&nbsp;&nbsp;Vitamin K Market, By Region

9.1&nbsp;&nbsp;&nbsp; Key regional trends

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Switzerland

9.3.7&nbsp;&nbsp;&nbsp; Rest of Europe

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; China

9.4.2&nbsp;&nbsp;&nbsp; Japan

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; South Korea

9.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Rest of Latin America

9.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

9.6.1&nbsp;&nbsp;&nbsp; South Africa

9.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.3&nbsp;&nbsp;&nbsp; Rest of Middle East &amp; Africa

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; Amphastar Pharmaceuticals, Inc.

10.2&nbsp;&nbsp;&nbsp; BASF SE

10.3&nbsp;&nbsp;&nbsp; Country Life, LLC (Kikkoman Corporation)

10.4&nbsp;&nbsp;&nbsp; DSM

10.5&nbsp;&nbsp;&nbsp; Kappa Bioscience

10.6&nbsp;&nbsp;&nbsp; Livealth Biopharma Pvt. Ltd.

10.7&nbsp;&nbsp;&nbsp; NattoPharma ASA

10.8&nbsp;&nbsp;&nbsp; NOW Foods

10.9&nbsp;&nbsp;&nbsp; Pfizer Inc.

10.10&nbsp;&nbsp;&nbsp; Solgar Inc 
&nbsp;

Vitamin K Market

Inquiry Before Buying

Industries

Information

Link

Global Headquarters